CLINICAL_TRIALS
research
· 2016-03-04
Clinical Trial Update: Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects
Summary
Observational study assessing anti-Tat immune responses in HIV-1-infected adults on HAART.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Barbara Ensoli, MD | Conditions: HIV Infection | Status: COMPLETED